Eculizumab Versus Rituxmab for Acetylcholine Receptor-positive Generalized Myasthenia Gravis: Single-center Experience

Clinical Effectiveness of Efgartigimod in Acetylcholine Receptor-positive Generalized Myasthenia Gravis